|
|
The genetic polymorphism of C jejuni determines autoantibody reactivity as well as the clinical presentation of Guillain-Barr syndrome (GBS), possibly through modification of the host-mimicking molecule. The GBS paradigm is the first to explain the detailed pathogenesis of a postinfectious, autoimmune-mediated, molecular mimicry-triggering disorder. |
|